Navigation Links
Other highlights in the September 11 JNCI
Date:9/11/2007

Nearly a third of prostate biopsies resulted in a cancer diagnosis among a population of older men on Medicare. Men whose first biopsy did not find cancer often had multiple biopsies in the future, which increased the chance of a cancer diagnosis.

While PSA (prostate-specific antigen) tests have become widely used in prostate cancer screening, a biopsy is what actually determines the presence of prostate cancer. Nonetheless, it remains unclear whether or not PSA screening actually reduces prostate cancer mortality.

H. Gilbert Welch, M.D., of the Department of Veterans Affairs Medical Center in White River Junction, Vt., and colleagues estimated the proportion of prostate biopsies that result in a cancer diagnosis and the likelihood of finding cancer with subsequent biopsies after the first one was negative. The researchers analyzed the outcomes of 10,429 biopsies performed from 1993 to 2001 in 8,273 men aged 65 and older.

About one third of prostate biopsies detected cancer, and the proportion of biopsies that found cancer increased as men got older. Among men whose first biopsy did not show cancer, about one third of them had another biopsy within five years. Nearly half of men who had a second biopsy were diagnosed with cancer, and the chance of diagnosis increased with each subsequent biopsy.

Because the goal of screening is to reduce deaths from the disease and not simply to find more cancer, the utility of [repeated biopsies warrant] careful reassessment, the authors write.

Contact: H. Gilbert Welch, h.gilbert.welch@dartmouth.edu, (802) 296-5178


Immune System Gene May Influence Lung Cancer Survival

Variations in a gene that influences the innate immune systemthe part of the immune system that provides short-term protection against infectionmay be associated with lung cancer survival.

Curtis Harris, M.D., of the National Cancer Institute in Bethesda, Md., and colleagues examined whether any of five variations of the MBL2 gene influenced survival among 558 white patients and 173 African-American patients with nonsmall-cell lung cancer.

Some gene variants were associated with improved survival among white patients, but not African-American patients. White patients who did not have the gene variants had poorer survival, particularly the heavy smokers.

This study may provide insight into the continued disparity in lung cancer survival between African-American and white patients, the authors write.

Contact: National Cancer Institute press office, ncipressofficers@mail.nih.gov, (301) 496-6641


Virus Targets Brain Cancer Stem Cells

Brain cancer stem cells are susceptible to a cancer-killing virus, which caused the death of brain tumors cells in mice and in test cells.

To achieve long-term remission, a treatment for brain cancer must kill the brain tumor stem cells that are resistant to radiation and chemotherapy.

Hong Jiang, Ph.D., of the University of Texas M.D. Anderson Cancer Center in Houston and colleagues tested whether the virus could be targeted to brain tumor cells. They were able to infect four cancer stem cell lines with the virus, which caused the cells to die. Mice with brain tumors from the cancer stem cells lived longer when they were injected with the virus than those given an inactivated version.

Our data are important because brain tumor stem cells are the driving force sustaining tumor growth, and therefore developing therapies to target the brain tumor stem cells should be a more effective strategy than conventional treatments, the authors write.

Contact: Scott Merville, external communications office, M. D. Anderson Cancer Center, sdmerville@mdanderson.org, (713) 792-0661


'/>"/>

Contact: Liz Savage
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
Source:Eurekalert

Related medicine news :

1. Another ray of hope for Arthritis Sufferers
2. Another injectable contraceptive Pill approved by FDA
3. Endangered species may be successfully cloned in another animals womb
4. Acupuncture May Help Chemotherapy Side Effects
5. Spouses and other partners lower blood pressure says new research
6. Yet Another Harmful Consequence Of Smoking
7. Grandmother’s diet in pregnancy can affect grandchildren’s blood sugr
8. UK Facing Shortage of Radiotherapists Delaying Cancer Treatment
9. Radiotherapy helps in colon cancer
10. Allergies are related to mothers menses
11. Mothers with periodontitis may deliver premature babies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented ... in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
(Date:6/24/2016)... 24, 2016  Consumers have taken a more ... placed more emphasis on patient outcomes. ... in the pharmaceutical industry have evolved beyond just ... companies are focusing on becoming more patient-oriented across ... and services that improve health. ...
(Date:6/24/2016)... , June 24, 2016  Global Blood Therapeutics, ... company developing novel therapeutics for the treatment of ... announced the closing of its previously announced underwritten ... at the public offering price of $18.75 per ... were offered by GBT. GBT estimates net proceeds ...
Breaking Medicine Technology: